Open Access iconOpen Access

ARTICLE

crossmark

A Metabolism-Related Gene Signature Predicts the Prognosis of Breast Cancer Patients: Combined Analysis of High-Throughput Sequencing and Gene Chip Data Sets

Lei Hu1,2,#, Meng Chen2,3,#, Haiming Dai2,3,4, Hongzhi Wang2,3,4,*, Wulin Yang2,3,4,*

1 School of Basic Medical Sciences, Wannan Medical College, Wuhu, 241001, China
2 Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China
3 Science Island Branch, Graduate School of University of Science and Technology of China, Hefei, 230026, China
4 Department of Pathology, Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, 230031, China

* Corresponding Authors: Hongzhi Wang. Email: email; Wulin Yang. Email: email
# The authors contributed equally to this work

(This article belongs to the Special Issue: Biomarkers for Breast Cancer Diagnosis and Treatment Selection: from Basic Research to Practice)

Oncologie 2022, 24(4), 803-822. https://doi.org/10.32604/oncologie.2022.026419

Abstract

Background and Aim: Hundreds of consistently altered metabolic genes have been identified in breast cancer (BC), but their prognostic value remains to be explored. Therefore, we aimed to build a prediction model based on metabolism-related genes (MRGs) to guide BC prognosis. Methods: Current work focuses on constructing a novel MRGs signature to predict the prognosis of BC patients using MRGs derived from the Virtual Metabolic Human (VMH) database, and expression profiles and clinicopathological data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Results: The 3-MRGs-signature constructed by SERPINA1, QPRT and PXDNL was found to be an independent prognostic factor for the survival of patients, and based on the model, the overall survival (OS) of the high-risk group was significantly lower. Furthermore, a nomogram was developed based on risk score and independent prognostic clinical indicators, and its validity of survival prediction was confirmed by the calibration curve, the concordance index, decision curve analysis and receiver operating characteristic curve. The ssGSEA analysis showed a negative correlation between immune cell infiltration and risk score, which is consistent with the GSEA result showing that low-risk score group was associated with activated immune processes. Half-maximal inhibitory concentration of chemotherapeutic drugs was estimated by pRRophetic algorithm to guide clinical medication. Conclusion: We constructed and validated an effective 3-MRGs (SERPINA1, QPRT and PXDNL)-based prognostic model, and demonstrated that lower-risk patients were associated with higher immune infiltrations, underscoring the importance of immune ecosystems in determining the prognosis of BC patients.

Keywords


Cite This Article

APA Style
Hu, L., Chen, M., Dai, H., Wang, H., Yang, W. (2022). A metabolism-related gene signature predicts the prognosis of breast cancer patients: combined analysis of high-throughput sequencing and gene chip data sets. Oncologie, 24(4), 803-822. https://doi.org/10.32604/oncologie.2022.026419
Vancouver Style
Hu L, Chen M, Dai H, Wang H, Yang W. A metabolism-related gene signature predicts the prognosis of breast cancer patients: combined analysis of high-throughput sequencing and gene chip data sets. Oncologie . 2022;24(4):803-822 https://doi.org/10.32604/oncologie.2022.026419
IEEE Style
L. Hu, M. Chen, H. Dai, H. Wang, and W. Yang "A Metabolism-Related Gene Signature Predicts the Prognosis of Breast Cancer Patients: Combined Analysis of High-Throughput Sequencing and Gene Chip Data Sets," Oncologie , vol. 24, no. 4, pp. 803-822. 2022. https://doi.org/10.32604/oncologie.2022.026419



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1348

    View

  • 662

    Download

  • 0

    Like

Share Link